[Crohn's disease and the SAPHO syndrome during treatment with infliximab: a case report and review of literature].
We report the case of a 40 year-old Turkish woman with severe ileal Crohn's disease associated with palmoplantar pustulosis and aseptic spondylitis, also known as the SAPHO syndrome. However, in the present case, the syndrome developed three months after starting infliximab (Remicade) therapy, which is generally used to treat the SAPHO syndrome. This case-report discusses the unclear relationship between Crohn's disease, the appearance of a SAPHO syndrome and treatment with infliximab.
Van Den Eynde
Marc
M
Service de Gastroentérologie, Clinique Saint-Jean, boulevard du Jardin Botanique 32, 1000 Brussels.
Lecluyse
Katrien
K
Chioccioli
Cristiano
C
Brouckaert
Marie
M
Caussin
Emmanuelle
E
Lammens
Pierre
P
D020083:Acquired Hyperostosis Syndrome / Q000139:chemically induced*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab